Sponsor:
Memorial Sloan Kettering Cancer Center
Code:
NCT05787574
Conditions
Primary Immune Regulatory Disorder
Autoimmune Lymphoproliferative
Immune System Diseases
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Emapalumab
Fludarabine and Dexamethasone
Stem Cell Transplant
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations